Showing results (21-30 of 570) with videos related to
Sort By:
Pageof 57
Clinical and Experimental Immunology|July 1, 1975
The influence of C3b inactivator (KAF) concentration on the ability of serum to support complement activationP J Lachmann, L HalbwachsScandinavian Journal of Immunology|January 1, 1976
Factor B of the alternative complement pathway on human lymphocytesL Halbwachs, P J LachmannClinical and Experimental Immunology|November 1, 1979
Conglutinin binding polyethylene glycol precipitation assay for immune complexesM Macanovic, P J LachmannClinical and Experimental Immunology|January 1, 1977
Haemolytic assays in agarose plates for components of the classical complement pathway: interference by the alternative pathwayA Martin, P J LachmannEuropean Journal of Immunology|August 1, 1988
The regulation of IgG subclass production in man: low serum IgG4 in inherited deficiencies of the classical pathway of C3 activationP Bird, P J LachmannEuropean Journal of Immunology|March 1, 1975
The failure to show a necessary role for C3 in the in vitro antibody responseH Waldmann, P J LachmannClinical and Experimental Immunology|March 1, 1990
Bispecific antibody: a tool for diagnosis and treatment of diseaseS Songsivilai, P J LachmannThe Journal of Biological Chemistry|March 25, 1984
Kidney and liver metallothioneins in rats after administration of an organic compoundE Giroux, P J LachmannImmunology|January 1, 1994
Glycosylation of IgA is required for optimal activation of the alternative complement pathway by immune complexesW Zhang, P J LachmannPageof 57